Exosomes as Carriers for Antitumor Therapy

ACS Biomater Sci Eng. 2019 Oct 14;5(10):4870-4881. doi: 10.1021/acsbiomaterials.9b00417. Epub 2019 Sep 9.

Abstract

Exosomes are bilayer vesicles with particle sizes between 50 and 150 nm. Owing to their bilayer membrane structure, cell-to-cell communication, and good absorbability, exosomes are increasingly used as carriers for drug delivery through phospholipid membrane structures to lesion sites with enhanced targeting. Exosome sources and drug-loading methods are important factors affecting their use as drug carriers. There are various ways to pack species in exosomes, and researchers are constantly seeking new and improved approaches. In both in vivo and in vitro evaluations, exosomal vectors have achieved good antitumor efficacies. Despite the importance of exosomes as drug delivery systems with accurate targeting ability and biocompatibility, improvements are needed to facilitate their widespread clinical use. This review focuses on the preparation of exosomes as carriers and their utilization in antitumor research.

Keywords: biomimetic nanocarriers; nanomedicine; tumor targeting.